Imaging in real-time with FRET the redox response of tumorigenic cells to glutathione perturbations in a microscale flow

Chunchen Lin, Vladimir L. Kolossov, Gene Tsvid, Lisa Trump, Jennifer Jo Henry, Jerrod L. Henderson, Laurie A. Rund, Paul J A Kenis, Lawrence B Schook, H Rex Gaskins, Gregory Timp

Research output: Contribution to journalArticle

Abstract

Despite the potential benefits of selective redox-modulating strategies for cancer therapy, an efficacious methodology for testing therapies remains elusive because of the difficulty in measuring intracellular redox potentials over time. In this report, we have incorporated a new FRET-based biosensor to follow in real time redox-sensitive processes in cells transformed to be tumorigenic and cultured in a microfluidic channel. A microfluidic network was used to control micro-scale flow near the cells and at the same time deliver drugs exogenously. Subsequently, the response of a redox homeostasis circuit was tested, namely reduced glutathione (GSH)/oxidized glutathione(GSSG), to diamide, a thiol oxidant, and two drugs used for cancer therapies: BSO (l-buthionine-[SR]-sulfoximine) and BCNU (carmustine). The main outcome from these experiments is a comparison of the temporal depletion and recovery of GSH in single living cells in real-time. These data demonstrate that mammalian cells are capable of restoring a reduced intracellular redox environment in minutes after an acute oxidative insult is removed. This recovery is significantly delayed by (i) the inhibition of GSH biosynthesis by BSO; (ii) the inactivation of glutathione reductase by BCNU; and (iii) in tumorigenic cells relative to an isogenic non-tumorigenic control cell line.

Original languageEnglish (US)
Pages (from-to)208-217
Number of pages10
JournalIntegrative Biology
Volume3
Issue number3
DOIs
StatePublished - Mar 1 2011

Fingerprint

Oxidation-Reduction
Glutathione
Carmustine
Imaging techniques
Microfluidics
Glutathione Disulfide
Cells
Diamide
Buthionine Sulfoximine
Recovery
Glutathione Reductase
Biosynthesis
Biosensing Techniques
Sulfhydryl Compounds
Oxidants
Biosensors
Pharmaceutical Preparations
Neoplasms
Homeostasis
Therapeutics

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry

Cite this

Lin, C., Kolossov, V. L., Tsvid, G., Trump, L., Henry, J. J., Henderson, J. L., ... Timp, G. (2011). Imaging in real-time with FRET the redox response of tumorigenic cells to glutathione perturbations in a microscale flow. Integrative Biology, 3(3), 208-217. https://doi.org/10.1039/c0ib00071j

Imaging in real-time with FRET the redox response of tumorigenic cells to glutathione perturbations in a microscale flow. / Lin, Chunchen; Kolossov, Vladimir L.; Tsvid, Gene; Trump, Lisa; Henry, Jennifer Jo; Henderson, Jerrod L.; Rund, Laurie A.; Kenis, Paul J A; Schook, Lawrence B; Gaskins, H Rex; Timp, Gregory.

In: Integrative Biology, Vol. 3, No. 3, 01.03.2011, p. 208-217.

Research output: Contribution to journalArticle

Lin, Chunchen ; Kolossov, Vladimir L. ; Tsvid, Gene ; Trump, Lisa ; Henry, Jennifer Jo ; Henderson, Jerrod L. ; Rund, Laurie A. ; Kenis, Paul J A ; Schook, Lawrence B ; Gaskins, H Rex ; Timp, Gregory. / Imaging in real-time with FRET the redox response of tumorigenic cells to glutathione perturbations in a microscale flow. In: Integrative Biology. 2011 ; Vol. 3, No. 3. pp. 208-217.
@article{6733a7232e8141ffa30fc00b4c6e05c9,
title = "Imaging in real-time with FRET the redox response of tumorigenic cells to glutathione perturbations in a microscale flow",
abstract = "Despite the potential benefits of selective redox-modulating strategies for cancer therapy, an efficacious methodology for testing therapies remains elusive because of the difficulty in measuring intracellular redox potentials over time. In this report, we have incorporated a new FRET-based biosensor to follow in real time redox-sensitive processes in cells transformed to be tumorigenic and cultured in a microfluidic channel. A microfluidic network was used to control micro-scale flow near the cells and at the same time deliver drugs exogenously. Subsequently, the response of a redox homeostasis circuit was tested, namely reduced glutathione (GSH)/oxidized glutathione(GSSG), to diamide, a thiol oxidant, and two drugs used for cancer therapies: BSO (l-buthionine-[SR]-sulfoximine) and BCNU (carmustine). The main outcome from these experiments is a comparison of the temporal depletion and recovery of GSH in single living cells in real-time. These data demonstrate that mammalian cells are capable of restoring a reduced intracellular redox environment in minutes after an acute oxidative insult is removed. This recovery is significantly delayed by (i) the inhibition of GSH biosynthesis by BSO; (ii) the inactivation of glutathione reductase by BCNU; and (iii) in tumorigenic cells relative to an isogenic non-tumorigenic control cell line.",
author = "Chunchen Lin and Kolossov, {Vladimir L.} and Gene Tsvid and Lisa Trump and Henry, {Jennifer Jo} and Henderson, {Jerrod L.} and Rund, {Laurie A.} and Kenis, {Paul J A} and Schook, {Lawrence B} and Gaskins, {H Rex} and Gregory Timp",
year = "2011",
month = "3",
day = "1",
doi = "10.1039/c0ib00071j",
language = "English (US)",
volume = "3",
pages = "208--217",
journal = "Integrative biology : quantitative biosciences from nano to macro",
issn = "1757-9694",
publisher = "Royal Society of Chemistry",
number = "3",

}

TY - JOUR

T1 - Imaging in real-time with FRET the redox response of tumorigenic cells to glutathione perturbations in a microscale flow

AU - Lin, Chunchen

AU - Kolossov, Vladimir L.

AU - Tsvid, Gene

AU - Trump, Lisa

AU - Henry, Jennifer Jo

AU - Henderson, Jerrod L.

AU - Rund, Laurie A.

AU - Kenis, Paul J A

AU - Schook, Lawrence B

AU - Gaskins, H Rex

AU - Timp, Gregory

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Despite the potential benefits of selective redox-modulating strategies for cancer therapy, an efficacious methodology for testing therapies remains elusive because of the difficulty in measuring intracellular redox potentials over time. In this report, we have incorporated a new FRET-based biosensor to follow in real time redox-sensitive processes in cells transformed to be tumorigenic and cultured in a microfluidic channel. A microfluidic network was used to control micro-scale flow near the cells and at the same time deliver drugs exogenously. Subsequently, the response of a redox homeostasis circuit was tested, namely reduced glutathione (GSH)/oxidized glutathione(GSSG), to diamide, a thiol oxidant, and two drugs used for cancer therapies: BSO (l-buthionine-[SR]-sulfoximine) and BCNU (carmustine). The main outcome from these experiments is a comparison of the temporal depletion and recovery of GSH in single living cells in real-time. These data demonstrate that mammalian cells are capable of restoring a reduced intracellular redox environment in minutes after an acute oxidative insult is removed. This recovery is significantly delayed by (i) the inhibition of GSH biosynthesis by BSO; (ii) the inactivation of glutathione reductase by BCNU; and (iii) in tumorigenic cells relative to an isogenic non-tumorigenic control cell line.

AB - Despite the potential benefits of selective redox-modulating strategies for cancer therapy, an efficacious methodology for testing therapies remains elusive because of the difficulty in measuring intracellular redox potentials over time. In this report, we have incorporated a new FRET-based biosensor to follow in real time redox-sensitive processes in cells transformed to be tumorigenic and cultured in a microfluidic channel. A microfluidic network was used to control micro-scale flow near the cells and at the same time deliver drugs exogenously. Subsequently, the response of a redox homeostasis circuit was tested, namely reduced glutathione (GSH)/oxidized glutathione(GSSG), to diamide, a thiol oxidant, and two drugs used for cancer therapies: BSO (l-buthionine-[SR]-sulfoximine) and BCNU (carmustine). The main outcome from these experiments is a comparison of the temporal depletion and recovery of GSH in single living cells in real-time. These data demonstrate that mammalian cells are capable of restoring a reduced intracellular redox environment in minutes after an acute oxidative insult is removed. This recovery is significantly delayed by (i) the inhibition of GSH biosynthesis by BSO; (ii) the inactivation of glutathione reductase by BCNU; and (iii) in tumorigenic cells relative to an isogenic non-tumorigenic control cell line.

UR - http://www.scopus.com/inward/record.url?scp=79952514307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952514307&partnerID=8YFLogxK

U2 - 10.1039/c0ib00071j

DO - 10.1039/c0ib00071j

M3 - Article

C2 - 21183971

AN - SCOPUS:79952514307

VL - 3

SP - 208

EP - 217

JO - Integrative biology : quantitative biosciences from nano to macro

JF - Integrative biology : quantitative biosciences from nano to macro

SN - 1757-9694

IS - 3

ER -